AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | – | 0 | – | 0.00% | – |
Q2 2023 | $0 | – | 0 | – | 0.00% | – |
Q1 2023 | $0 | – | 0 | – | 0.00% | – |
Q4 2022 | $0 | – | 0 | – | 0.00% | – |
Q3 2022 | $0 | – | 0 | – | 0.00% | – |
Q2 2022 | $0 | – | 0 | – | 0.00% | – |
Q1 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2021 | $5,000 | -28.6% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $7,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -33.3% | 1,000 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $9,000 | -47.1% | 1,000 | -33.3% | 0.00% | 0.0% |
Q3 2020 | $17,000 | – | 1,500 | – | 0.00% | – |
Q2 2020 | $0 | – | 0 | – | 0.00% | – |
Q1 2020 | $0 | – | 0 | – | 0.00% | – |
Q4 2019 | $0 | – | 0 | – | 0.00% | – |
Q3 2019 | $0 | – | 0 | – | 0.00% | – |
Q2 2019 | $0 | – | 0 | – | 0.00% | – |
Q1 2019 | $0 | – | 0 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |